Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

6 resultsUpdated October 23, 2026
1

Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan

Frontiers in Pharmacology 11 (2020)

Saima Mushtaq; Tayyab Saeed Akhter; Amjad Khan; Amjad Khan; Aamir Sohail; Arshad Khan; Arshad Khan; Sobia Manzoor

2

Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals

Frontiers in Pharmacology 13 (2022)

Saima Mushtaq; Asraf Hussain Hashmi; Amjad Khan; Syed Muhammad Asad Raza Kazmi; Sobia Manzoor

3

Direct‐acting antiviral agents in the treatment of chronic hepatitis C—Real‐life experience from clinical practices in Pakistan

Journal of Medical Virology 92(12) (2020)

Saima Mushtaq; Atika Mansoor; Muhammad Umar; Amjad Khan; Saima Siddiqi; Sobia Manzoor

5

Emergence of resistance against direct acting antivirals in chronic HCV patients: A real-world study

Saudi Journal of Biological Sciences 29(4) (2021)

Abdul Majid; Sanaullah Khan; Sami Siraj; Sumbal Haleem; Najib ul Haq; Riaz Ullah; Essam A. Ali; Adeela Mustafa; Hidayat Hussain; Muhammad Sohaib

6

Comparison of Efficacy of Sofosbuvir & Daclatasvir with Sofosbuvir and Velpatasvir in Achieving SVR in Patients of Chronic Hepatitis C with Genotype 3

Pakistan Journal of Medical and Health Sciences 16(4) (2022)

Tanveer Ahmed; Omer Hassaan Aftab Ahmad; Muhammad Bilal; Sher Alam; Shirjeel Zaheer; Zaid Gul